1. Home
  2. PLSE vs BHE Comparison

PLSE vs BHE Comparison

Compare PLSE & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • BHE
  • Stock Information
  • Founded
  • PLSE 2014
  • BHE 1979
  • Country
  • PLSE United States
  • BHE United States
  • Employees
  • PLSE N/A
  • BHE N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • BHE Electrical Products
  • Sector
  • PLSE Health Care
  • BHE Technology
  • Exchange
  • PLSE Nasdaq
  • BHE Nasdaq
  • Market Cap
  • PLSE 1.1B
  • BHE 1.3B
  • IPO Year
  • PLSE 2016
  • BHE 1990
  • Fundamental
  • Price
  • PLSE $17.32
  • BHE $36.73
  • Analyst Decision
  • PLSE
  • BHE Strong Buy
  • Analyst Count
  • PLSE 0
  • BHE 2
  • Target Price
  • PLSE N/A
  • BHE $47.00
  • AVG Volume (30 Days)
  • PLSE 154.2K
  • BHE 237.9K
  • Earning Date
  • PLSE 05-08-2025
  • BHE 04-29-2025
  • Dividend Yield
  • PLSE N/A
  • BHE 1.87%
  • EPS Growth
  • PLSE N/A
  • BHE N/A
  • EPS
  • PLSE N/A
  • BHE 1.44
  • Revenue
  • PLSE N/A
  • BHE $2,612,294,000.00
  • Revenue This Year
  • PLSE N/A
  • BHE $0.52
  • Revenue Next Year
  • PLSE N/A
  • BHE $8.50
  • P/E Ratio
  • PLSE N/A
  • BHE $25.26
  • Revenue Growth
  • PLSE N/A
  • BHE N/A
  • 52 Week Low
  • PLSE $9.70
  • BHE $30.73
  • 52 Week High
  • PLSE $25.00
  • BHE $52.57
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 52.20
  • BHE 52.04
  • Support Level
  • PLSE $16.75
  • BHE $35.62
  • Resistance Level
  • PLSE $18.26
  • BHE $37.07
  • Average True Range (ATR)
  • PLSE 0.87
  • BHE 0.74
  • MACD
  • PLSE 0.03
  • BHE 0.04
  • Stochastic Oscillator
  • PLSE 62.80
  • BHE 58.93

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.

Share on Social Networks: